News release
From:
Attachments
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Research
JAMA, Web page
Please link to the article in online versions of your report (the URL will go live after the embargo ends).
Journal/
conference: JAMA
conference: JAMA
Research:Paper
Organisation/s:
The University of Chicago, USA
Funder:
The trial was funded by Alnylam
Pharmaceuticals. Medical writing support was
provided by PharmaGenesis Cardiff, UK and was
funded by Alnylam Pharmaceuticals, Cambridge,
MA, USA, in accordance with Good Publication
Practice (GPP 2022) guidelines (www.ismpp.org/
gpp-2022)